Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
CA 2361013 A1 · Owner: Bamdad, R. Shoshana · Inventors: Bamdad, R. Shoshana; Bamdad, Cynthia Carol
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods, assays, and components are described in which biological samples can be rapidly and sensitively analyzed for the presence of species associated with neurodegenerative disease. Techniques and components are provided for diagnosis of disease, as well as for screening of candidate drugs for treatment of neurodegenerative disease. The techniques are simple extremely , sensitive, and utilize readily-available components. Binding species capable , of binding a neurodegenerative disease aggregate-forming or fibril-forming species, are fastened to surfaces of electrodes and surfaces of particles or , provided free in solution, to bind fibril-forming species and/or be involved in …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 25, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 25, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 25, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.